{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:49:31Z","timestamp":1775180971326,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1181462"],"award-info":[{"award-number":["1181462"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1-PDF-2020-969-A-N"],"award-info":[{"award-number":["1-PDF-2020-969-A-N"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009881","name":"Juvenile Diabetes Research Foundation Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ajpath.2025.09.006","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:29:33Z","timestamp":1759282173000},"page":"562-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting ROR\u03b3 to Boost Regulatory T cells and Ameliorate Diabetic Retinopathy in Mice"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0390-3454","authenticated-orcid":false,"given":"Devy","family":"Deliyanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9581-803X","authenticated-orcid":false,"given":"Varaporn","family":"Suphapimol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phoebe","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhirup","family":"Jayasimhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Wilkinson-Berka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2025.09.006_bib1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/bjo.2010.191312","article-title":"The impact of diabetic retinopathy: understanding the patient's perspective","volume":"95","author":"Fenwick","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib2","article-title":"Diabetic retinopathy: looking forward to 2030","volume":"13","author":"Tan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajpath.2025.09.006_bib3","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajpath.2025.09.006_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.64.5.28","article-title":"Mechanisms of acquired resistance to anti-VEGF therapy for neovascular eye diseases","volume":"64","author":"Sharma","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2025.09.006_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajo.2016.09.012","article-title":"Early and long-term responses to anti-vascular endothelial growth factor therapy in diabetic macular edema: analysis of protocol I data","volume":"172","author":"Gonzalez","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"Tang","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajpath.2025.09.006_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101799","article-title":"Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications","volume":"37","author":"Kang","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12974-023-02740-x","article-title":"Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies","volume":"20","author":"Vargas-Soria","year":"2023","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.ajpath.2025.09.006_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.564077","article-title":"Microglia and inflammatory responses in diabetic retinopathy","volume":"11","author":"Kinuthia","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib10","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/ATVBAHA.115.307080","article-title":"Inhibition of the nuclear receptor ROR\u03b3 and interleukin-17A suppresses neovascular retinopathy: involvement of immunocompetent microglia","volume":"36","author":"Talia","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib11","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1167\/iovs.10-5768","article-title":"TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis","volume":"52","author":"Huang","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2025.09.006_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108508","article-title":"Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy","volume":"9","author":"Rangasamy","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2025.09.006_bib13","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1167\/iovs.09-3375","article-title":"Role of IL-6 in angiotensin II-induced retinal vascular inflammation","volume":"51","author":"Rojas","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2025.09.006_bib14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/ATVBAHA.122.318079","article-title":"CD8+ T cells promote pathological angiogenesis in ocular neovascular disease","volume":"43","author":"Deliyanti","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib15","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00125-025-06412-8","article-title":"Immunotherapy with low-dose IL-2 attenuates vascular injury in mice with diabetic and neovascular retinopathy by restoring the balance between Foxp3+ Tregs and CD8+ T cells","volume":"68","author":"Deliyanti","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajpath.2025.09.006_bib16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41467-017-00751-w","article-title":"Foxp3+ Tregs are recruited to the retina to repair pathological angiogenesis","volume":"8","author":"Deliyanti","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2025.09.006_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8546423","article-title":"Levels of inflammatory cytokines IL-1\u03b2, IL-6, IL-8, IL-17A, and TNF-\u03b1 in aqueous humour of patients with diabetic retinopathy","volume":"2018","author":"Feng","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.ajpath.2025.09.006_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/0301-4738.151464","article-title":"Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy","volume":"63","author":"Chernykh","year":"2015","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2024.106862","article-title":"Berberine alleviates diabetic retinopathy by regulating the Th17\/Treg ratio","volume":"267","author":"Yang","year":"2024","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ajpath.2025.09.006_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of Treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of TH17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2025.09.006_bib22","article-title":"The alterations in and the role of the Th17\/Treg balance in metabolic diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175427","article-title":"Oral administration of CU06-1004 attenuates vascular permeability and stabilizes neovascularization in retinal vascular diseases","volume":"939","author":"Noh","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib24","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/db22-0970","article-title":"The early pathogenesis of diabetic retinopathy and its attenuation by sodium-glucose transporter 2 inhibitors","volume":"73","author":"Yamato","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.ajpath.2025.09.006_bib25","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/art.38272","article-title":"Pharmacologic repression of retinoic acid receptor\u2013related orphan nuclear receptor \u03b3 is therapeutic in the collagen-induced arthritis experimental model","volume":"66","author":"Chang","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib26","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cell.2019.03.010","article-title":"A multiscale map of the stem cell state in pancreatic adenocarcinoma","volume":"177","author":"Lytle","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2025.09.006_bib27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/HYPERTENSIONAHA.119.14100","article-title":"Nox (NADPH oxidase) 1, Nox4, and Nox5 promote vascular permeability and neovascularization in retinopathy","volume":"75","author":"Deliyanti","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpath.2025.09.006_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134392","article-title":"FT011, a novel cardiorenal protective drug, reduces inflammation, gliosis and vascular injury in rats with diabetic retinopathy","volume":"10","author":"Deliyanti","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2025.09.006_bib29","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.3390\/ijms24032334","article-title":"Finerenone, a non-steroidal mineralocorticoid receptor antagonist, reduces vascular injury and increases regulatory T-cells: studies in rodents with diabetic and neovascular retinopathy","volume":"24","author":"Jerome","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2025.09.006_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12950-025-00431-3","article-title":"Alpha-1 antitrypsin reduces inflammation and vasculopathy in mice with oxygen-induced retinopathy","volume":"22","author":"Suphapimol","year":"2025","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.ajpath.2025.09.006_bib31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/en.2014-1677","article-title":"ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes","volume":"156","author":"Solt","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajpath.2025.09.006_bib32","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.3390\/ijms21103547","article-title":"ROR\u03b3t Inhibitor-SR1001 halts retinal inflammation, capillary degeneration, and the progression of diabetic retinopathy","volume":"21","author":"Zapadka","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2025.09.006_bib33","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1021\/cb3002649","article-title":"Identification of a selective ROR\u03b3 ligand that suppresses TH17 cells and stimulates T regulatory cells","volume":"7","author":"Solt","year":"2012","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib34","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/bph.13453","article-title":"Digoxin reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"173","author":"Shi","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/TP.0b013e31827a48f5","article-title":"Digoxin attenuates acute cardiac allograft rejection by antagonizing ROR\u03b3t activity","volume":"95","author":"Wu","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.ajpath.2025.09.006_bib36","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.4049\/jimmunol.0903243","article-title":"RORC2 is involved in T cell polarization through interaction with the FOXP3 promoter","volume":"184","author":"Burgler","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2008.08.001","article-title":"From the diet to the nucleus: vitamin A and TGFbeta join efforts at the mucosal interface of the intestine","volume":"21","author":"Mucida","year":"2008","journal-title":"Semin Immunol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-024-00724-w","article-title":"Regulatory T cells limit age-associated retinal inflammation and neurodegeneration","volume":"19","author":"Llori\u00e1n-Salvador","year":"2024","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.ajpath.2025.09.006_bib39","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3390\/ijms24021347","article-title":"Anti-IL17A halts the onset of diabetic retinopathy in type I and II diabetic mice","volume":"24","author":"Zhou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2025.09.006_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2019.04.009","article-title":"Diabetes-mediated IL-17A enhances retinal inflammation, oxidative stress, and vascular permeability","volume":"341","author":"Sigurdardottir","year":"2019","journal-title":"Cell Immunol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib41","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1159\/000460514","article-title":"Blocking IL-17A alleviates diabetic retinopathy in rodents","volume":"41","author":"Qiu","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.ajpath.2025.09.006_bib42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13578-021-00593-6","article-title":"Blocking the interaction between interleukin-17A and endoplasmic reticulum stress in macrophage attenuates retinal neovascularization in oxygen-induced retinopathy","volume":"11","author":"Wang","year":"2021","journal-title":"Cell Biosci"},{"key":"10.1016\/j.ajpath.2025.09.006_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.117","article-title":"IL-17A exacerbates diabetic retinopathy by impairing M\u00fcller cell function via Act1 signaling","volume":"48","author":"Qiu","year":"2016","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.ajpath.2025.09.006_bib44","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jdiacomp.2019.05.016","article-title":"Diabetes induces IL-17A-Act1-FADD-dependent retinal endothelial cell death and capillary degeneration","volume":"33","author":"Lindstrom","year":"2019","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ajpath.2025.09.006_bib45","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00417-014-2842-9","article-title":"Effect of the blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced diabetic retinopathy in rats","volume":"253","author":"Xu","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2025.09.006_bib47","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.immuni.2016.04.007","article-title":"A progenitor cell expressing transcription factor ROR\u03b3t generates all human innate lymphoid cell subsets","volume":"44","author":"Scoville","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2025.09.006_bib48","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/eji.200838331","article-title":"Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells","volume":"38","author":"Gu","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jmcb\/mjs065","article-title":"ROR\u03b3t+IL-17+ neutrophils play a critical role in hepatic ischemia-reperfusion injury","volume":"5","author":"Tan","year":"2013","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ni.1681","article-title":"Influence of the transcription factor ROR\u03b3t on the development of NKp46+ cell populations in gut and skin","volume":"10","author":"Luci","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib51","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2337\/dc13-2002","article-title":"Ocular anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy","volume":"37","author":"Sim\u00f3","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpath.2025.09.006_bib52","first-page":"1001","article-title":"Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development","volume":"9","author":"Agarwal","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib53","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3390\/ijms24021747","article-title":"IL-17A enhances retinal neovascularization","volume":"24","author":"Taylor","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2025.09.006_bib54","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nm.3291","article-title":"An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy","volume":"19","author":"Chung","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2025.09.006_bib55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/cei.12295","article-title":"Interleukin-6 blockade in ocular inflammatory diseases","volume":"176","author":"Mesquida","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ajpath.2025.09.006_bib56","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.4049\/jimmunol.1102602","article-title":"IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection","volume":"188","author":"Suryawanshi","year":"2012","journal-title":"J Immunol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025003633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025003633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:09:28Z","timestamp":1775178568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944025003633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0002944025003633"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.09.006","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting ROR\u03b3 to Boost Regulatory T cells and Ameliorate Diabetic Retinopathy in Mice","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}